Characterization of the Hen as a Model for Human Ovarian Cancer

Abstract

Investigation of basic factors involved in malignant transformation of the ovary has been hampered by the lack of an appropriate animal model. Most animals, with the exception of the domestic hen, do not spontaneously develop ovarian cancer. The use of two related genetic strains, which differ in spontaneous incidence of ovarian cancer may reveal an important difference between the two strains that could underlie the differential susceptibility to ovarian cancer We have accumulated many hens of both strains and have observed an increasing incidence of the tumors with age The C strain of hens was found to have a significantly higher plasma level of estradiol compared to the K strain. This was in spite of no difference in progesterone or laying rate. All ovarian tumors that we have examined express ovalbumin which may indicate that de-differentiation occurs during the disease process. Ovarian surface epithelial cells, the presumed site of origin of the tumors, express estrogen and progesterone receptors. Ovarian tumors also express progesterone receptors, associated with the glandular areas of proliferation. Finally, the transcription factor COUP-TFII which regulates ovalbumin production, is present in RNA isolated from tumor cells.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2004
Accession Number
ADA429761

Entities

People

  • Patricia A. Johnson

Organizations

  • Cornell University

Tags

DTIC Thesaurus Topics

  • Albumins
  • Antigens
  • Biomedical Research
  • Blood
  • Cancer
  • Cell Physiological Processes
  • Cells
  • Diseases And Disorders
  • Epithelial Cells
  • Estrogens
  • Hormones
  • Neoplasms
  • Ovarian Cancer
  • Progesterone
  • Proteins
  • Sex Glands
  • Urogenital System

Fields of Study

  • Biology

Readers

  • Mechanical Engineering/Mechanics of Materials.
  • Molecular Biology and Genetics
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech